Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus

E-ISSN： 2212-4063|14|1|64-70

ISSN： 1871-529X

Source： Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.14, Iss.1, 2014-03, pp. : 64-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 485-497

Bentham Science Publishers

Access to resources Recommend Favorite

Association of CTLA-4 (++49A/G) Gene Polymorphism with Type 1 Diabetes Mellitus in Egyptian Children

By Mosaad Youssef M. Elsharkawy Ashraf A. El-Deek Basem S.

Immunological Investigations, Vol. 41, Iss. 1, 2012-01 ,pp. : 28-37

Informa Healthcare

Access to resources Recommend Favorite

Oxidative stress parameters in type 2 diabetes mellitus

By Kassab A. Laradi S. Ferchichi S. Omezzine A. Charfeddine B. Ammar H. Chaieb L. Miled A.

Immunoanalyse & Biologie Specialisee, Vol. 18, Iss. 2, 2003-04 ,pp. : 79-85

Elsevier

Access to resources Recommend Favorite

Serine Kinases as New Drug Targets for the Treatment of Type 2 Diabetes

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 529-536

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of CYP2C9 gene polymorphisms on response to treatment with sulfonylureas in a cohort of Egyptian type 2 diabetes mellitus patients

By Salam Randa Zeyada Reham Osman Noha

Comparative Clinical Pathology, Vol. 23, Iss. 2, 2014-03 ,pp. : 341-346

Springer Publishing Company

Access to resources Recommend Favorite